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journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORGeneralized follicular mucinosis treated
with narrow band ultraviolet B radiationDear Editor,
A 28-year-old man presented with a 2-year history of pru-
ritic skin eruptions. The dermatological examination
revealed erythematous or skin-colored follicular papules
and plaques on the scalp, face, trunk and upper extremities
(Figure 1). He was otherwise healthy. The hemogram, liver
and renal function tests, and sedimentation rate were
normal. VDRL tests for syphilis, antinuclear antibodies, and
antiextractable nuclear antigen antibodies were negative.
The histopathology of the lesions showed spongiosis and
acanthosis in the epidermis, spongiosis and a material
collection in the follicular epithelium, and a mild peri-
appendiceal, perivascular and interstitial lymphocytic
infiltrate with no atypical lymphocytes. Alcian blue stain
was positive in hair follicles (Figure 1). The patient was
diagnosed with follicular mucinosis (FM) based on the
clinical and histological findings.
A peripheral blood smear examination and thor-
acoabdominal computed tomography were normal. Ultra-
sonography showed multiple enlarged lymph nodes in the
submandibular, axillary and inguinal regions bilaterally
(ranging from 14  6 to 35  6 mm). The patient refused
lymph node excision.
Rupatadine 10 mg/day was started to treat the severe
pruritus until the histopathological results were obtained.
The dosage was increased to 4  10 mg/day and 150 mg
pregabalin/day was added because the pruritus did not
decrease. The patient was given 40 mg triamcinolone ace-
tonide intramuscularly 1 week later, when the pruritus did
not respond to these drugs. After the histopathology was
revealed, oral isotretinoin 20 mg/day was started. However,
the drug was discontinued after 3 days because of increased
erythema and exacerbation of the lesions. Subsequently, the
patient was started on narrow-band ultraviolet B (NB-UVB)
three times perweek. The pruritus and lesions healed almost
completely by the third week of NB-UVB therapy (Figure 1).Conflicts of interest: All authors declare no conflicts of interest.
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disorder characterized by follicular papules and plaques on
the scalp, face and neck, and mucin deposition in the
follicular epithelium and less frequently the sebaceous
glands. The primary form of the disease usually affects
children and young adults. The secondary form usually af-
fects adults and is associated with other benign or malig-
nant conditions, most often mycosis fungoides (MF). The
clinical features of the primary and secondary forms are
identical and histopathology is essential for the diagnosis.
Mucin deposition in hair follicles may be seen in MF [1]. Our
patient was diagnosed with primary FM, because the lym-
phocytic infiltrate was mild and the infiltrate was peri-
vascular and interstitial, rather than follicular as in MF. In
addition, no atypical lymphocytes were observed. Some
authors believe that FM is an indolent form of MF; more-
over, approximately 15e30% of primary FM develops into
MF. Therefore, patient follow-up is recommended [1].
There is no uniformly effective therapy for FM. Primary
FM may resolve spontaneously in 2e24 months. There are
various treatment options for FM, including topical/sys-
temic corticosteroids, topical retinoids, dapsone, indo-
methacin, minocycline, psoralen and ultraviolet A radiation
and methotrexate [1]. NB-UVB has been reported to be
ineffective in the treatment of FM [2].
Our case is interesting because the lesions were gener-
alized, which is a rare form of FM, and the disease responded
well to NB-UVB. NB-UVB is a reliable and often preferred
option for several dermatoses such as atopic dermatitis,
vitiligo, cutaneous T-cell lymphoma and psoriasis [3].
We do not know the exact mechanism of action of NB-
UVB on FM. UVB radiation can penetrate into the der-
moepidermal junction and superficial dermis [4]. Follic-
ular keratinocytes have been considered to be the source
of mucin in FM. It has been proposed that cell-mediated
immune mechanisms, including a reaction to persistent
antigen, may play a role in the pathogenesis of FM
[5]. UVB suppresses Langerhans cells and alters their an-
tigen presenting function. Therapeutic UVB also inhibitsby Elsevier Taiwan LLC. This is an open access article under the
4.0/).
Figure 1. (A) Follicular papules and plaques before treatment; (B) complete resolution of the lesions after three weeks of narrow
band UVB treatment; (C) spongiosis and acanthosis in the epidermis, spongiosis and a material collection in the follicular
epithelium (H & E  40,  100); and (D) mucin deposition in hair follicles (Alcian blue  200,  400).
Letter to the Editor 435inflammation by reducing proinflammatory cytokine pro-
duction by T lymphocytes [3]. Therefore we think that
although UVB cannot penetrate into the deep dermis, it
may inhibit mucin production indirectly by affecting
epidermal keratinocytes and/or immune system cells such
as Langerhans cells and T lymphocytes on epidermis,
dermoepidermal junction and superficial dermis.
In conclusion, NB-UVB may be considered as an alter-
native in the treatment of primary FM as no single treat-
ment has been shown to be consistently effective.
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